(Q38083537)

28 August 2017

1 reference

26 November 2020

No room to breathe: the importance of lung hyperinflation in COPD (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6442765&resulttype=core&format=json

13 May 2020

1 reference

26 November 2020

chronic obstructive pulmonary disease

1 reference

26 November 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6442765&resulttype=core&format=json

13 May 2020

author name string

Marc Decramer

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6442765&resulttype=core&format=json

13 May 2020

Denis E O'Donnell

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6442765&resulttype=core&format=json

13 May 2020

publication date

1 March 2013

2 references

Primary care respiratory journal : journal of the General Practice Airways Group

28 August 2017

26 November 2020

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6442765&resulttype=core&format=json

13 May 2020

26 November 2020

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6442765&resulttype=core&format=json

13 May 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6442765&resulttype=core&format=json

13 May 2020

page(s)

101-111

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6442765&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.4104/pcrj.2013.00025

13 May 2020

exact match

0 references

cites work

International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

Prevalence and underdiagnosis of chronic obstructive pulmonary disease among patients at risk in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

Global burden of COPD: risk factors, prevalence, and future trends

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

Lung function impairment, COPD hospitalisations and subsequent mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

Activity limitation and quality of life in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

The nature of small-airway obstruction in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

Small-airway obstruction and emphysema in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

COPD exacerbations . 3: Pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

Hyperinflation, Dyspnea, and Exercise Intolerance in Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

Respiratory muscle function and activation in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

Diaphragm length during tidal breathing in patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

Respiratory muscle dysfunction in COPD: from muscles to cell

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

Physiological changes during symptom recovery from moderate exacerbations of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

Lung mechanics and dyspnea during exacerbations of chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

Exacerbations of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

Tiotropium versus salmeterol for the prevention of exacerbations of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

The effect of lung volume reduction surgery on chronic obstructive pulmonary disease exacerbations

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

The language of breathlessness differentiates between patients with COPD and age-matched adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

Affective descriptors of the sensation of breathlessness are more highly associated with severity of impairment than physical descriptors in people with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

Lung hyperinflation and its reversibility in patients with airway obstruction of varying severity.

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

Daily physical activity in patients with chronic obstructive pulmonary disease is mainly associated with dynamic hyperinflation.

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

Dynamic hyperinflation during daily activities: does COPD global initiative for chronic obstructive lung disease stage matter?

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

Diaphragm adaptations in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

Characteristics of physical activities in daily life in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

Extrapulmonary effects of chronic obstructive pulmonary disease on physical activity: a cross-sectional study.

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

Physical activity in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

Treatment of COPD: the sooner the better?

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

COPD as a lung disease with systemic consequences--clinical impact, mechanisms, and potential for early intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

Prediction of the rate of decline in FEV(1) in smokers using quantitative Computed Tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

The progression of chronic obstructive pulmonary disease is heterogeneous: the experience of the BODE cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

Changes in forced expiratory volume in 1 second over time in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

Outcomes for COPD pharmacological trials: from lung function to biomarkers.

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

Role of inspiratory capacity on exercise tolerance in COPD patients with and without tidal expiratory flow limitation at rest

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

Improvement in Resting Inspiratory Capacity and Hyperinflation With Tiotropium in COPD Patients With Increased Static Lung Volumes *

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

Reduction of hyperinflation by pharmacologic and other interventions.

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

Combined physiological effects of bronchodilators and hyperoxia on exertional dyspnoea in normoxic COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

Activity promotion: a paradigm shift for chronic obstructive pulmonary disease therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

Optimizing pulmonary rehabilitation in chronic obstructive pulmonary disease--practical issues: a Canadian Thoracic Society Clinical Practice Guideline.

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

Diagnosis and Management of Stable Chronic Obstructive Pulmonary Disease: A Clinical Practice Guideline Update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

Pulmonary Rehabilitation: Joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

Effect of salmeterol on respiratory muscle activity during exercise in poorly reversible COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

Mechanical loading and control of breathing in patients with severe chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

Pathophysiology of dyspnea in chronic obstructive pulmonary disease: a roundtable

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

The role of domiciliary nebulizers in managing patients with severe COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

Sustained 24-hour efficacy of once daily indacaterol (300 μg) in patients with chronic obstructive pulmonary disease: a randomized, crossover study.

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

The safety and efficacy of arformoterol and formoterol in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

Addition of salmeterol to existing treatment in patients with COPD: a 12 month study

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

Computed tomography assessment of pharmacological lung volume reduction induced by bronchodilators in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

The effect of tiotropium on hyperinflation and exercise capacity in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

Once-daily NVA237 improves exercise tolerance from the first dose in patients with COPD: the GLOW3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

Comparison of efficacy of long-acting bronchodilators in emphysema dominant and emphysema nondominant chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

Bronchodilation improves endurance but not muscular efficiency in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

Aclidinium bromide improves exercise endurance and lung hyperinflation in patients with moderate to severe COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

Efficacy and safety of nebulized formoterol as add-on therapy in COPD patients receiving maintenance tiotropium bromide: Results from a 6-week, randomized, placebo-controlled, clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

Effects of arformoterol twice daily, tiotropium once daily, and their combination in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

Effects of tiotropium with and without formoterol on airflow obstruction and resting hyperinflation in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

Additive benefits of tiotropium in COPD patients treated with long-acting beta agonists and corticosteroids.

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

Superiority of "triple" therapy with salmeterol/fluticasone propionate and tiotropium bromide versus individual components in moderate to severe COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

Efficacy and tolerability of budesonide/formoterol added to tiotropium in patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

Effect of combination treatment on lung volumes and exercise endurance time in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

Budesonide added to formoterol contributes to improved exercise tolerance in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

Bronchodilator responsiveness and onset of effect with budesonide/formoterol pMDI in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

Clinical and functional benefits of adding theophylline to a standard treatment with short acting bronchodilators in patients with COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

Effect of tiotropium bromide on the cardiovascular response to exercise in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

A randomized, controlled trial of theophylline in patients with severe chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

Effect of N-acetylcysteine on air trapping in COPD: a randomized placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

Effects of tiotropium and formoterol on dynamic hyperinflation and exercise endurance in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

International Primary Care Respiratory Group (IPCRG) Guidelines: Management of Chronic Obstructive Pulmonary Disease (COPD)

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

Effect of Fluticasone Propionate/Salmeterol on Lung Hyperinflation and Exercise Endurance in COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

Formoterol by Pressurized Metered-Dose Aerosol or Dry Powder on Airway Obstruction and Lung Hyperinflation in Partially Reversible COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2013.00025

Spirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary disease

21 January 2018

1 reference

12 December 2020

Respiratory muscle activity in patients with COPD walking to exhaustion with and without pressure support

1 reference

12 December 2020

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary

1 reference

12 December 2020

Respiratory muscles in COPD: regulation of trophical status

1 reference

12 December 2020

Pulmonary rehabilitation for chronic obstructive pulmonary disease

1 reference

12 December 2020

Theophylline and Salbutamol Improve Pulmonary Function in Patients with Irreversible Chronic Obstructive Pulmonary Disease

1 reference

12 December 2020

Effects of formoterol on exercise tolerance in severely disabled patients with COPD

1 reference

12 December 2020

Fast onset of effect of budesonide/formoterol versus salmeterol/fluticasone and salbutamol in patients with chronic obstructive pulmonary disease and reversible airway obstruction

1 reference

12 December 2020

Mechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary disease

1 reference

12 December 2020

Hyperinflation and its management in COPD

1 reference

12 December 2020

Long-term effect of the beta2-receptor agonist procaterol on daily life performance and exercise capacity in patients with stable chronic obstructive pulmonary disease. Clinical study with special reference to health-related quality of life and acti

1 reference

12 December 2020

The major limitation to exercise performance in COPD is dynamic hyperinflation

1 reference

12 December 2020

Contractile properties of the human diaphragm during chronic hyperinflation

1 reference

12 December 2020

Pulmonary rehabilitation 2007: from bench to practice and back.

1 reference

12 December 2020

Tiotropium and exercise training in COPD patients: effects on dyspnea and exercise tolerance

1 reference

12 December 2020

Mechanisms of activity-related dyspnea in pulmonary diseases

1 reference

12 December 2020

Effects of oxygen on exercise duration in chronic obstructive pulmonary disease patients before and after pulmonary rehabilitation

1 reference

12 December 2020

Low inspiratory capacity to total lung capacity ratio is a risk factor for chronic obstructive pulmonary disease exacerbation

1 reference

12 December 2020

The efficacy of tiotropium bromide (spiriva) in the treatment of patients with chronic obstructive pulmonary disease of varying severity: results of the Russian trial

1 reference

12 December 2020

Effect of indacaterol on exercise endurance and lung hyperinflation in COPD

1 reference

12 December 2020

Effect of indacaterol on dynamic lung hyperinflation and breathlessness in hyperinflated patients with COPD

1 reference

12 December 2020

Decline of resting inspiratory capacity in COPD: the impact on breathing pattern, dyspnea, and ventilatory capacity during exercise

1 reference

12 December 2020

Evolution of Dyspnea during Exercise in Chronic Obstructive Pulmonary Disease

1 reference

12 December 2020

Effect of adjunct fluticasone propionate on airway physiology during rest and exercise in COPD

1 reference

12 December 2020

Physiological effects of roflumilast at rest and during exercise in COPD

1 reference

12 December 2020

Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease

1 reference

12 December 2020

Sub-clinical left ventricular diastolic dysfunction in early stage of chronic obstructive pulmonary disease

1 reference

12 December 2020

Effects of beclomethasone/formoterol fixed combination on lung hyperinflation and dyspnea in COPD patients

1 reference

12 December 2020

Quadriceps wasting and physical inactivity in patients with COPD

1 reference

12 December 2020

Concurrent use of indacaterol plus tiotropium in patients with COPD provides superior bronchodilation compared with tiotropium alone: a randomised, double-blind comparison

1 reference

12 December 2020

Lung Function Decline in Male Heavy Smokers Relates to Baseline Airflow Obstruction Severity

1 reference

12 December 2020

Tough at the top: must end-expiratory lung volume make way for end-inspiratory lung volume?

1 reference

12 December 2020

Effects of theophylline on diaphragmatic strength and fatigue in patients with chronic obstructive pulmonary disease

1 reference

12 December 2020

Partitioning of work of breathing in mechanically ventilated COPD patients.

1 reference

12 December 2020

Hyperinflation, trapped gas and theophylline in chronic obstructive pulmonary disease

1 reference

12 December 2020

Peripheral muscle weakness contributes to exercise limitation in COPD

1 reference

12 December 2020

Effect of chronic hyperinflation on diaphragm length and surface area.

1 reference

12 December 2020

Cellular adaptations in the diaphragm in chronic obstructive pulmonary disease

1 reference

12 December 2020

Identifiers

DOI

10.4104/PCRJ.2013.00025

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6442765&resulttype=core&format=json

Dimensions Publication ID

13 May 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6442765&resulttype=core&format=json

13 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6442765&resulttype=core&format=json